4 models fit Weyco Group Inc. Common Stock and they partly agree: 2 of 4 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Silver71
Valued as a cyclical company: P/E comparison, EV/EBITDA comparison, Discounted cash flow, and Graham number.
ACCE opinionWeyco Group Inc. Common Stock (WEYS)
Fair value (4 models)
$33.10
ACCE price target
$54.00
Rating
Overvalued
Horizon
12 months
Fair value published on 10 Oct 2026, 00:00 CEST; previously $40.73 since 6 Oct 2026, 00:00 CEST.
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Rating published on 18 Oct 2026, 17:04 CEST.
Price used: $50.70 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, EV/EBITDA comparison, Graham number, and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
53.2% above
-34.7% to fair value
ACCE score
82
out of 100
P/E
13.9x
forward 35.0x
1-year return
+69.8%
Dividend yield
2.12%
Weyco Group Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Weyco Group designs and sources footwear under its Florsheim, Nunn Bush and Stacy Adams brands, and sells through department stores, specialty retailers and its own outlets and e-commerce. Its edge is a long-established dress and casual shoe franchise with a 49.1% gross margin and a 27.5% operating margin, both well above what most footwear makers earn, which points to brand pricing power rather than volume. Revenue grew 6.9% and the stock trades at 11.8 times forward earnings against 14.5 times trailing, so the market is pricing in earnings growth without paying a premium for it. The company is small, with a market cap of about $495 million and no index membership, which limits institutional coverage and may leave the valuation gap open longer than the fundamentals alone would suggest. The thesis needs checking on whether the 6.9% growth is durable across the wholesale and direct-to-consumer channels and whether margins hold as wholesale customers push back on pricing.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
moderate
Earnings growth flattered by base effect
Earnings are up 483.8% YoY but revenue grew only 6.9%, so the jump largely reflects a depressed prior-year base rather than a durable step-up. Treat the trailing P/E of 14.3 with caution.
moderate
Sharp quarter-on-quarter decline
Latest quarter-on-quarter change is -15.8%, which is worth checking against seasonality before reading it as a trend. Forward P/E of 35.9 versus trailing 14.3 signals analysts expect earnings to fall back.
moderate
Price sits near ACCE target
The stock trades 6.1% below the ACCE price target of $54.00, leaving limited upside to that level, and 53.2% above the model fair value of $33.10.
AI research notes
AI-assisted·How I use AIWritten Oct 19, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 6.9% year over year and has averaged 7.2% a year over five years, a steady growth record.
Free cash flow of $36M over the last twelve months and a 7.2% free cash flow yield show the business turns sales into cash.
Debt is minimal at 0.05 times equity, and the diluted share count fell 0.4% last fiscal year, so shareholders are not diluted.
Why it could disappoint
The stock trades 53.2% above the model fair value of $33.10, and all four valuation models sit below the share price.
At 35.9x forward earnings the shares cost nearly twice the sector median of 18.1x, pricing in growth well beyond recent trends.
Analysts' mean price target of $26.00 sits 50.1% below the share price, and return on invested capital of 7.6% is modest for a company this size.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 3, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where WEYS's valuation models land
Price
$50.70
Model fair value
$33.10
Model range
$20.84 to $39.68
Fair value $33.10
Price $50.70
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores
+Score history: how each score moved over time
Analysts
Wall Street consensus
No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
+Price-target low / average / high vs the current price, with implied upside
+Forward revenue and EPS consensus by fiscal year
+ACCE fair-value models lined up against the Street
Smart Money
PRO
In one line
Trades are only made public after a delay. We show the delay so you know how old the news is.